Literature DB >> 16351634

Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?

S J Stanworth1, C Hyde, S Brunskill, M F Murphy.   

Abstract

National guidelines for platelet transfusion in many countries recommend that the general platelet transfusion trigger for prophylaxis is 10x10(9)/l. This annotation reviews the evidence for this threshold level and discusses other current unresolved issues relevant to platelet transfusion practice such as the optimal dose and the clinical benefit of a strategy for the prophylactic use of platelet transfusions when the platelet count falls below a given threshold.

Entities:  

Mesh:

Year:  2005        PMID: 16351634     DOI: 10.1111/j.1365-2141.2005.05769.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

Review 1.  Recommendations for the transfusion of plasma and platelets.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

2.  Multiple electrode aggregometry and thromboelastography in thrombocytopenic patients with haematological malignancies.

Authors:  Elin N Opheim; Torunn O Apelseth; Simon J Stanworth; Geir E Eide; Tor Hervig
Journal:  Blood Transfus       Date:  2018-12-13       Impact factor: 3.443

Review 3.  Indications for platelet transfusion in patients with thrombocytopenia.

Authors:  Jerry E Squires
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

4.  A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Gemma L Crighton; Erica M Wood; Simon Stanworth; Marialena Trivella; Carolyn Doree; Alan Tinmouth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2014

5.  Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

Review 6.  How to further develop the evidence base for transfusion medicine.

Authors:  Michael F Murphy; Susan Brunskill; Lise Estcourt; Simon Stanworth; Carolyn Dorée
Journal:  Blood Transfus       Date:  2012-10       Impact factor: 3.443

7.  Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.

Authors:  Giuseppe Tagariello; Giancarlo Castaman; Anna Falanga; Rita Santoro; Mariasanta Napolitano; Sergio Storti; Dino Veneri; Marco Basso; Laura Candiotto; Cristina Tassinari; Augusto B Federici; Valerio De Stefano
Journal:  Blood Transfus       Date:  2016-06-24       Impact factor: 3.443

8.  Bleeding After Endoscopic Procedures in Patients With Chronic Hematologic Thrombocytopenia.

Authors:  Hyun Jin Oh; Jae Myung Park; Seung Bae Yoon; Han Hee Lee; Chul-Hyun Lim; Jin Su Kim; Yu Kyung Cho; Bo-In Lee; Young-Seok Cho; Myung-Gyu Choi
Journal:  Dig Dis Sci       Date:  2016-12-29       Impact factor: 3.199

9.  Dose of prophylactic platelet transfusions and prevention of hemorrhage.

Authors:  Sherrill J Slichter; Richard M Kaufman; Susan F Assmann; Jeffrey McCullough; Darrell J Triulzi; Ronald G Strauss; Terry B Gernsheimer; Paul M Ness; Mark E Brecher; Cassandra D Josephson; Barbara A Konkle; Robert D Woodson; Thomas L Ortel; Christopher D Hillyer; Donna L Skerrett; Keith R McCrae; Steven R Sloan; Lynne Uhl; James N George; Victor M Aquino; Catherine S Manno; Janice G McFarland; John R Hess; Cindy Leissinger; Suzanne Granger
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

Review 10.  Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Patricia Blanco; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.